Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06588595 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Switching Antiplatelet-9 (SWAP-9) Study

Name: The Switching Antiplatelet-9 (SWAP-9) Study — clinical trial record (NCT06588595)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SWAP-9

StatusRecruiting

PhasePhase 4

SponsorUniversity of Florida

Started2024-11-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated February 25, 2026 (before its estimated August 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-02-24

Study Status v2

Re-verified, no change to tracked fields

2025-02-06

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Study sitesdetails revised at 1 of 1 site

2024-09-06

Original filing

University of Florida

325 trials monitored

See 23 trials at risk

Coronary Artery Disease

1,518 trials monitored

See 65 trials at risk

The purpose of this study is to compare the pharmacodynamic effects of ABCD-GENE guided vs. unguided de-escalation strategies among patients on dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI).

Trial Details

NCT Number	NCT06588595
Lead Sponsor	University of Florida
Conditions	Coronary Arterial Disease (CAD)
Enrollment	90 participants
Start Date	2024-11-01
Primary Completion	2026-08-30 (estimated)
Study Completion	2027-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-02-25